-88%

est. 2Y upside i

HealthcareSeries C

Rank

#3672

Sector

Healthcare AI / Radiology Software

Est. Liquidity

~4Y

Data Quality

Data: Low

Despite strong market position and high growth, the current valuation of $525M implies a 39x multiple on stale $13.4M ARR, far above public SaaS comps (8-12x), leading to negative expected equity upside (-88%) over 2 years.

Last updated: July 19, 2026

Bull (10%)-64%

IPO window and category leadership sustain high multiple (~15x). Revenue reaches $19.7M, exit value $295M, but after 20% dilution and preference, common equity returns -63.8%.

Base (50%)-83%

Multiple converges to public comps (~10x). Revenue $19.7M yields $197M exit, after dilution and preference common returns -82.6%.

Bear (40%)-100%

Multiple compresses to 6x, exit $118M below $158M preference stack, common stock recovers 0%. Incumbent Microsoft/Nuance intensifies competition.

Est. time to liquidity~4.0 years

Preference Stack Risk

severe

Funding Intensity

117910%

Total preferred stock of $158M is 30% of current valuation, creating significant overhang for common equity.

Dilution Risk

high

With $60M raised in Jan 2025 and negative profitability, a future raise within 24 months is probable, diluting common by ~20%.

Secondary Liquidity

none

No secondary market exists; employee equity is illiquid until a liquidity event (IPO or acquisition).

General & Administrative 1 role

Implementations 1 role

ML & Data 1 role

Sales 1 role

View all 10 open roles at Radai

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Radai's data — designed to show you've done your homework.

  • 1

    How do you plan to differentiate from Microsoft's Nuance integration into PowerScribe given their 80% market share?

  • 2

    What is the unit economics (LTV/CAC) and how does it evolve with scale?

  • 3

    Given the negative expected equity return, what is the typical dilution and liquidity timeline for employees?

Community

Valuation Sentiment

Our model estimates -88% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.